Published in Acta Neuropathol on June 17, 2004
TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer (2010) 1.73
The tyrosine kinase pyk2 promotes migration and invasion of glioma cells. Neoplasia (2005) 1.60
EFEMP1 suppresses malignant glioma growth and exerts its action within the tumor extracellular compartment. Mol Cancer (2011) 1.22
The dual kinase complex FAK-Src as a promising therapeutic target in cancer. Onco Targets Ther (2010) 1.22
Targeting Pyk2 for therapeutic intervention. Expert Opin Ther Targets (2010) 1.04
TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling. Mol Cancer Res (2010) 1.03
Targeting FAK in human cancer: from finding to first clinical trials. Front Biosci (Landmark Ed) (2014) 0.99
The Pyk2 FERM domain as a target to inhibit glioma migration. Mol Cancer Ther (2009) 0.98
Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts. J Neurooncol (2008) 0.90
Mesenchymal migration as a therapeutic target in glioblastoma. J Oncol (2010) 0.89
miRNA expression profiling in migrating glioblastoma cells: regulation of cell migration and invasion by miR-23b via targeting of Pyk2. PLoS One (2012) 0.89
Downregulation of FIP200 induces apoptosis of glioblastoma cells and microvascular endothelial cells by enhancing Pyk2 activity. PLoS One (2011) 0.83
Microglia Activate Migration of Glioma Cells through a Pyk2 Intracellular Pathway. PLoS One (2015) 0.81
Focal adhesion kinases in adhesion structures and disease. J Signal Transduct (2012) 0.81
Induction of proline-rich tyrosine kinase 2 activation-mediated C6 glioma cell invasion after anti-vascular endothelial growth factor therapy. J Transl Med (2014) 0.78
Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia. J Transl Med (2015) 0.78
Microparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer Cells. Front Oncol (2014) 0.77
Breast Cancer Malignant Processes are Regulated by Pax-5 Through the Disruption of FAK Signaling Pathways. J Cancer (2016) 0.75
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol (2000) 9.73
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain (2008) 3.05
Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain (2000) 2.90
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain (2008) 2.83
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol (1996) 2.41
Lymphocytic and granulomatous hypophysitis: experience with nine cases. Neurosurgery (1997) 2.37
Detection and prevention of the trigeminocardiac reflex during skull base surgery. Acta Neurochir (Wien) (2007) 2.28
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med (2001) 2.27
Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma. Cent Eur Neurosurg (2010) 2.24
Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab (1995) 2.00
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (2001) 1.94
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study. Eur J Endocrinol (2007) 1.83
Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol (1999) 1.75
Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol (1999) 1.71
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain (1999) 1.63
Difficult intubation in acromegalic patients: incidence and predictability. Anesthesiology (2000) 1.61
p73 is an essential regulator of neural stem cell maintenance in embryonal and adult CNS neurogenesis. Cell Death Differ (2010) 1.60
Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg (1999) 1.60
DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours. Eur J Endocrinol (2011) 1.48
Magnetic brain source imaging of focal epileptic activity: a synopsis of 455 cases. Brain (2003) 1.45
Patterns of oligodendroglia pathology in multiple sclerosis. Brain (1994) 1.44
Elevated inferior petrosal sinus levels of PTHrP in a patient with Cushing's disease. Clin Endocrinol (Oxf) (2001) 1.40
Remyelination capacity of the MS brain decreases with disease chronicity. Neurology (2009) 1.39
Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J Neuropathol Exp Neurol (1999) 1.38
Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol (1996) 1.36
Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials (2008) 1.31
Trigemino-cardiac reflex in humans initiated by peripheral stimulation during neurosurgical skull-base operations. Its first description. Acta Neurochir (Wien) (2008) 1.29
Piezoelectric bone surgery: a revolutionary technique for minimally invasive surgery in cranial base and spinal surgery? Technical note. Neurosurgery (2005) 1.24
A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease. Acta Neuropathol (2001) 1.21
Intraoperative magnetic resonance imaging with the magnetom open scanner: concepts, neurosurgical indications, and procedures: a preliminary report. Neurosurgery (1998) 1.20
The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol (2000) 1.19
Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry (2004) 1.18
Molecular imaging of brain tumors: a bridge between clinical and molecular medicine? Mol Imaging Biol (2007) 1.17
A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol (2001) 1.14
Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler (1998) 1.11
Intraoperative magnetic resonance imaging during transsphenoidal surgery. J Neurosurg (2001) 1.10
Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis (1999) 1.10
Somatostatin receptor expression in the thyroid demonstrated with 111In-octreotide scintigraphy. Nuklearmedizin (1995) 1.09
Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol (1995) 1.09
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II. J Neural Transm (Vienna) (2006) 1.07
Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol (1998) 1.07
Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol (2008) 1.06
Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol (Oxf) (1999) 1.05
Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect Immun (2001) 1.05
Immunopathology of primary hypophysitis: implications for pathogenesis. Am J Surg Pathol (2005) 1.04
Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control. Neurology (2012) 1.04
Coil migration after endovascular coil occlusion of internal carotid artery pseudoaneurysms within the sphenoid sinus. Minim Invasive Neurosurg (2009) 1.04
Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg (1999) 1.03
Interleukin-6 expression in human multiple sclerosis lesions. Neurosci Lett (2000) 1.03
Radiation therapy of optico-hypothalamic gliomas (OHG)--radiographic response, vision and late toxicity. Radiother Oncol (2000) 1.02
Octreotide exerts different effects in vivo and in vitro in Cushing's disease. Eur J Endocrinol (1994) 1.01
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry (2005) 1.01
Diffusion tensor imaging and white matter tractography in patients with brainstem lesions. Acta Neurochir (Wien) (2007) 1.01
Prediction of postoperative outcome with special respect to removal of hemosiderin fringe: a study in patients with cavernous haemangiomas associated with symptomatic epilepsy. Seizure (2007) 1.01
Intraoperative magnetic resonance imaging combined with neuronavigation: a new concept. Neurosurgery (2001) 1.01
Changes in fiber integrity, diffusivity, and metabolism of the pyramidal tract adjacent to gliomas: a quantitative diffusion tensor fiber tracking and MR spectroscopic imaging study. AJNR Am J Neuroradiol (2007) 1.01
Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia (2011) 0.99
Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology. Glia (2000) 0.99
Macrophages are eliminated from the injured peripheral nerve via local apoptosis and circulation to regional lymph nodes and the spleen. J Neurosci (2001) 0.98
Elimination of blood-derived macrophages inhibits the release of interleukin-1 and the entry of leukocytes into the cerebrospinal fluid in experimental pneumococcal meningitis. J Neuroimmunol (1997) 0.97
Magnetoencephalography in extratemporal epilepsy. J Clin Neurophysiol (2000) 0.97
Moxifloxacin in the therapy of experimental pneumococcal meningitis. Antimicrob Agents Chemother (1998) 0.97
Temporal lobe microdysgenesis in epilepsy versus control brains. J Neuropathol Exp Neurol (1999) 0.97
Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis. Neurology (2008) 0.97
Identification of glial cell proliferation in early multiple sclerosis lesions. Neuropathol Appl Neurobiol (1998) 0.96
Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas -- a study on 721 patients. Acta Neurochir (Wien) (2004) 0.96
Surgical management of acromegaly. Endocrinol Metab Clin North Am (1992) 0.95
Difference in functional outcome of ipsilateral tinnitus after intraoperative occurrence of the trigemino-cardiac reflex in surgery for vestibular schwannomas. Acta Neurochir (Wien) (2007) 0.95
Remyelination in multiple sclerosis. Mult Scler (1997) 0.95
The coexistence of pituitary adenomas and meningiomas: three case reports and a review of the literature. Br J Neurosurg (1989) 0.94
The role of TNF-alpha during Wallerian degeneration. J Neuroimmunol (2000) 0.94
Choroid plexus: the major site of mRNA expression for the beta-trace protein (prostaglandin D synthase) in human brain. Neurosci Lett (1996) 0.94
Lessons from the neuropathology of atypical forms of multiple sclerosis. Neurol Sci (2004) 0.94
Delayed trigeminocardiac reflex induced by an intraorbital foreign body. Ophthalmologica (2006) 0.94
[Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients]. Nervenarzt (2006) 0.94
Glioma surgery evaluated by intraoperative low-field magnetic resonance imaging. Acta Neurochir Suppl (2003) 0.93
Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis. J Antimicrob Chemother (1997) 0.93
Transsphenoidal surgery for Cushing's disease. J R Soc Med (1986) 0.93
Rifabutin for experimental pneumococcal meningitis. Chemotherapy (1997) 0.93
Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain (1998) 0.93
Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: rapid induction of Th1-type cytokines and inducible nitric oxide synthase. J Immunol (2000) 0.93
Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. J Neuropathol Exp Neurol (2001) 0.93
Serum procalcitonin monitoring for differential diagnosis of ventriculitis in adult intensive care patients. Intensive Care Med (2002) 0.92
Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury. Acta Neurochir Suppl (2010) 0.92
[Trigeminocardiac reflex in pituitary surgery. A prospective pilot study]. Nervenarzt (2008) 0.92
Transsphenoidal surgery of parasellar pituitary adenomas. Acta Neurochir (Wien) (1988) 0.91
Frameless stereotactic brain biopsy procedures using the Stealth Station: indications, accuracy and results. Zentralbl Neurochir (2003) 0.91
Heavy riboflavin synthase of Bacillus subtilis. Primary structure of the beta subunit. J Biol Chem (1987) 0.91
Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridization. Virchows Arch A Pathol Anat Histopathol (1991) 0.91
Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas. J Endocrinol (2012) 0.90
Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors. Neurosurgery (1993) 0.90
Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions. Mult Scler (2006) 0.90
Intrasellar malignant lymphoma developing within pituitary adenoma. Acta Neuropathol (1999) 0.90
Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy. Neurology (2007) 0.90
Image-guided removal of supratentorial cavernomas in critical brain areas: application of neuronavigation and intraoperative magnetic resonance imaging. Minim Invasive Neurosurg (2003) 0.90
Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat. Glia (2001) 0.90
Hypopituitarism in a HIV affected patient. Exp Clin Endocrinol Diabetes (2011) 0.90
Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly. J Clin Endocrinol Metab (2014) 0.89